Log in

NYSE:MCKMcKesson Stock Price, Forecast & News

-3.35 (-2.13 %)
(As of 08/5/2020 04:00 PM ET)
Today's Range
Now: $153.67
50-Day Range
MA: $152.23
52-Week Range
Now: $153.67
Volume1.23 million shs
Average Volume3.00 million shs
Market Capitalization$24.91 billion
P/E Ratio27.39
Dividend Yield1.04%
McKesson Corporation provides pharmaceuticals and medical supplies in the United States and internationally. It operates in three segments: U.S. Pharmaceutical and Specialty Solutions, European Pharmaceutical Solutions, and Medical-Surgical Solutions. The company distributes branded, generic, specialty, biosimilar, and over-the-counter pharmaceutical drugs, as well as other healthcare-related products; and offers practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices. It also provides specialty pharmaceutical solutions for pharmaceutical manufacturers; and medical-surgical supply distribution, logistics, and other services to healthcare providers. In addition, the company operates retail pharmacy chains in Europe and Canada, as well as supports independent pharmacy networks within North America and Europe; and supplies integrated pharmacy management systems, automated dispensing systems, and related services to retail, outpatient, central fill, specialty, and mail order pharmacies. Further, it provides software and analytics, network solutions, and technology-enabled services. The company serves retail national accounts, including national and regional chains, food and drug combinations, mail order pharmacies, and mass merchandisers; independent retail pharmacies; and institutional healthcare providers, such as hospitals, health systems, integrated delivery networks, and long-term care providers, as well as pharmaceutical manufacturers. McKesson Corporation was founded in 1833 and is headquartered in San Francisco, California.
Read More
McKesson logo

Beat the Market (BTM) Rank

Analyst Opinion: 3.4Community Rank: 3.1Dividend Strength: 1.7Insider Behavior: 1.0Valuation: 1.3 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

2.07 out of 5 stars

Industry, Sector and Symbol

Industry Drugs, proprietaries, & sundries
Sub-IndustryHealth Care Distributors



Sales & Book Value

Annual Sales$231.05 billion
Cash Flow$20.52 per share
Book Value$34.87 per share


Net Income$900 million


Market Cap$24.91 billion
Next Earnings Date11/4/2020 (Estimated)
-3.35 (-2.13 %)
(As of 08/5/2020 04:00 PM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive MCK News and Ratings via Email

Sign-up to receive the latest news and ratings for MCK and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles

McKesson (NYSE:MCK) Frequently Asked Questions

How has McKesson's stock been impacted by COVID-19 (Coronavirus)?

McKesson's stock was trading at $135.17 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, MCK shares have increased by 13.7% and is now trading at $153.67.
View which stocks have been most impacted by Coronavirus

Do Wall Street analysts recommend investors buy shares of McKesson?

14 Wall Street analysts have issued "buy," "hold," and "sell" ratings for McKesson in the last year. There are currently 4 hold ratings and 10 buy ratings for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for McKesson

When is McKesson's next earnings date?

McKesson is scheduled to release its next quarterly earnings announcement on Wednesday, November 4th 2020.
View our earnings forecast for McKesson

How were McKesson's earnings last quarter?

McKesson Co. (NYSE:MCK) posted its quarterly earnings results on Monday, August, 3rd. The company reported $2.77 earnings per share (EPS) for the quarter, topping the Zacks' consensus estimate of $2.27 by $0.50. The business had revenue of $55.68 billion for the quarter, compared to the consensus estimate of $54.16 billion. McKesson had a net margin of 0.40% and a return on equity of 42.33%. The firm's quarterly revenue was down .1% compared to the same quarter last year. During the same quarter last year, the company posted $3.31 earnings per share.
View McKesson's earnings history

How often does McKesson pay dividends? What is the dividend yield for McKesson?

McKesson declared a quarterly dividend on Wednesday, July 29th. Stockholders of record on Tuesday, September 1st will be paid a dividend of $0.42 per share on Thursday, October 1st. This represents a $1.68 annualized dividend and a dividend yield of 1.09%. The ex-dividend date of this dividend is Monday, August 31st. This is a boost from McKesson's previous quarterly dividend of $0.41.
View McKesson's dividend history

What guidance has McKesson issued on next quarter's earnings?

McKesson issued an update on its FY21 earnings guidance on Monday, August, 3rd. The company provided earnings per share (EPS) guidance of $14.70-15.50 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $14.39.

What price target have analysts set for MCK?

14 Wall Street analysts have issued 12 month target prices for McKesson's shares. Their forecasts range from $147.00 to $204.00. On average, they anticipate McKesson's share price to reach $179.08 in the next twelve months. This suggests a possible upside of 16.5% from the stock's current price.
View analysts' price targets for McKesson

Has McKesson been receiving favorable news coverage?

Media coverage about MCK stock has been trending somewhat negative recently, according to InfoTrie Sentiment. The research firm scores the sentiment of news coverage by analyzing more than six thousand news and blog sources. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores closest to five being the most favorable. McKesson earned a media sentiment score of -1.4 on InfoTrie's scale. They also gave news articles about the company a news buzz of 0.0 out of 10, indicating that recent news coverage is extremely unlikely to have an effect on the company's share price in the next several days.
View the latest news about McKesson

Are investors shorting McKesson?

McKesson saw a decrease in short interest in the month of July. As of July 31st, there was short interest totaling 2,420,000 shares, a decrease of 5.1% from the July 15th total of 2,550,000 shares. Based on an average daily trading volume, of 1,380,000 shares, the days-to-cover ratio is presently 1.8 days. Currently, 1.5% of the shares of the stock are sold short.
View McKesson's Current Options Chain

Who are some of McKesson's key competitors?

What other stocks do shareholders of McKesson own?

Based on aggregate information from My MarketBeat watchlists, some companies that other McKesson investors own include Walt Disney (DIS), Gilead Sciences (GILD), CVS Health (CVS), salesforce.com (CRM), UnitedHealth Group (UNH), Johnson & Johnson (JNJ), Allergan (AGN), Bank of America (BAC), AbbVie (ABBV) and Chevron (CVX).

Who are McKesson's key executives?

McKesson's management team includes the following people:
  • Mr. John H. Hammergren, Chairman & CEO (Age 60)
  • Britt J. Vitalone, CFO & Exec. VP (Age 50)
  • Ms. Lori A. Schechter, Chief Compliance Officer, Exec. VP & Gen. Counsel (Age 57)
  • Mr. Jorge L. Figueredo, Exec. VP & Chief HR Officer (Age 58)
  • Mr. Bansi Nagji, Exec. VP and Chief Strategy & Bus. Devel. Officer (Age 54)

What is McKesson's stock symbol?

McKesson trades on the New York Stock Exchange (NYSE) under the ticker symbol "MCK."

Who are McKesson's major shareholders?

McKesson's stock is owned by a variety of retail and institutional investors. Top institutional shareholders include Pzena Investment Management LLC (1.85%), LSV Asset Management (1.00%), Scharf Investments LLC (0.55%), Sumitomo Mitsui Trust Holdings Inc. (0.45%), Swiss National Bank (0.39%) and Strs Ohio (0.24%). Company insiders that own McKesson stock include Brian S Tyler, Brian Scott Tyler, Britt J Vitalone, Lori A Schechter, M Christine Jacobs, N Anthony Coles and Sundeep G Reddy.
View institutional ownership trends for McKesson

Which institutional investors are selling McKesson stock?

MCK stock was sold by a variety of institutional investors in the last quarter, including Prudential PLC, Pzena Investment Management LLC, Morningstar Investment Services LLC, MERIAN GLOBAL INVESTORS UK Ltd, BNP PARIBAS ASSET MANAGEMENT Holding S.A., SG Americas Securities LLC, Wedge Capital Management L L P NC, and First Trust Advisors LP. Company insiders that have sold McKesson company stock in the last year include Brian S Tyler, Britt J Vitalone, Lori A Schechter, and Sundeep G Reddy.
View insider buying and selling activity for McKesson

Which institutional investors are buying McKesson stock?

MCK stock was acquired by a variety of institutional investors in the last quarter, including UBS Group AG, Mackay Shields LLC, Strs Ohio, Assenagon Asset Management S.A., State of Alaska Department of Revenue, Raymond James Financial Services Advisors Inc., Railway Pension Investments Ltd, and Sumitomo Mitsui Trust Holdings Inc..
View insider buying and selling activity for McKesson

How do I buy shares of McKesson?

Shares of MCK can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is McKesson's stock price today?

One share of MCK stock can currently be purchased for approximately $153.67.

How big of a company is McKesson?

McKesson has a market capitalization of $24.91 billion and generates $231.05 billion in revenue each year. The company earns $900 million in net income (profit) each year or $14.95 on an earnings per share basis. McKesson employs 80,000 workers across the globe.

What is McKesson's official website?

The official website for McKesson is www.mckesson.com.

How can I contact McKesson?

McKesson's mailing address is 6555 STATE HWY 161, IRVING TX, 75039. The company can be reached via phone at 972-446-4800 or via email at [email protected]

This page was last updated on 8/6/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.